![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 38, 35156-35161, September 20, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
,
,
,
¶¶
From the
Department of Genetics and Developmental
Biology, University of Connecticut Health Center, Farmington,
Connecticut 06030, ¶ Karolinska Institutet, Department of
Bioscience and Center for Nutrition and Toxicology, Novum, SE-141
57 Huddinge, Sweden,
National Institute of Chemical Physics and
Biophysics and Center of Gene Technology, Tallinn Technical University,
Tallinn, Estonia, ** Unidad de Neurobiologia del Desarrollo,
Instituto de Neurociencias, Universidad Miguel Hernandezy CSIC, Campus
de San Juan, 03550 Alicante, Spain, § Department of
Pharmacology, University of Rochester, Rochester, New York 14642, 
Department of Genetics, Southeast
University Medical School, Nanjing, China, and
§§ Department of Medicine/Genetic Medicine,
Vanderbilt University, Nashville, Tennessee 37232
Received for publication, July 8, 2002, and in revised form, July 18, 2002
| |
ABSTRACT |
|---|
|
|
|---|
To investigate the cellular role of dual
specificity Yak1-related kinase (Dyrk) 1, a nuclear localized dual
specificity protein kinase, we examined its effect on transcriptional
regulation using reporter gene assays. We found that Dyrk1 can
substantially enhance Gli1-dependent, but not
LEF-1-, c-Jun-, or Elk-dependent, gene transcription. In part, Dyrk1 does this through retaining Gli1 in the
nucleus. However, we also demonstrate that Dyrk1 can enhance the
transcriptional activity of Gli1-AHA, a nuclear export mutant, suggesting that Dyrk1 may be more directly involved in regulating the
transcriptional activity of Gli1. In addition, Dyrk1 acted synergistically with Sonic hedgehog (Shh) to induce gene
transcription and differentiation in mouse C3H10T1/2 cells. The
failure of Shh to stimulate Dyrk1 kinase activity suggests that Dyrk1
may not be directly regulated by the Shh signaling pathway but
functionally interacts with it. Thus, Gli1 transcriptional
activity may be subjected to further regulation in the cell nucleus by
a pathway distinct from Shh signaling, one mediated by Dyrk1.
The dual specificity Yak1-related kinase
(Dyrk)1 gene family encodes
for dual specificity kinases that can phosphorylate serine/threonine and tyrosine residues (1, 2). Dyrks are distant members of the
mitogen-activated protein kinase family and also share sequence
similarity to cyclin-dependent kinases (3). The Dyrk family
in mammals consists of at least seven members, with four distinct
classes of Dyrk kinases (Dyrk1-4) (2). However, an increasing number
of Dyrk-like kinases also have been reported, including the
homeodomain-interacting protein kinase family, androgen receptor
protein kinase, and Myak (4-6).
Although the developmental importance of the Dyrk gene family remains
largely unknown, studies with Yak1 in yeast and minibrain (mnb) in Drosophila suggest their involvement in
regulating cell proliferation (7, 8). As the name suggests,
mnb mutant flies have a smaller brain size as a result of a
defect in neurogenesis (8). There is evidence in humans that the Dyrk1
class, a homolog of the Drosophila mnb gene,
contains three separate genes, Dyrk1a, Dyrk1b, and Dyrk1c (9).
Interestingly, Dyrk1a has been mapped to the Down's syndrome critical
region of chromosome 21, and transgenic mice harboring an extra copy of
this gene retain deficits in learning (10-12). This strongly suggests
that the Dyrk1/mnb class has evolved a conserved role that
is essential for proper brain development.
Cell transfection studies on GFP-tagged versions of Dyrk1a and
homeodomain-interacting protein kinase 2 have confirmed their nuclear
localization (2, 4). Interestingly, the staining pattern of GFP
fluorescence in the nucleus has revealed that Dyrk1a and
homeodomain-interacting protein kinase 2 associate with nuclear speckles, potential sites of alternative splicing or transcriptional regulation. Recently, studies with homeodomain-interacting protein kinase 2 have demonstrated its ability to associate with nuclear bodies, co-localize with PML3, and bind p53 and CREB-binding
protein, revealing its role in transcriptional regulation (13, 14). Consistent with the idea that nuclear localized Dyrks may regulate transcriptional activity, many of the protein substrates identified in
protein interactor screens involving Dyrk have been transcription factors. Biochemical studies with Dyrk1a have demonstrated its ability
to interact with the transcription factors Forkhead, CREB, and signal
transducers and activators of transcription 3 (15-17).
Cell transfection studies carried out in our laboratory have revealed
that Dyrk1a can dramatically enhance the transcriptional activity of
Gli1. Gli1, Gli2, and Gli3 are vertebrate homologs to the
Drosophila cubitus interruptus (ci) gene, a
five-zinc finger transcription factor whose function is highly
regulated by the hedgehog signaling pathway (18-20). Hedgehog genes
encode for secreted signaling proteins that can function as growth
factor and morphogen important for cell proliferation and pattern
formation (21-23). Analagous to Ci in Drosophila,
Gli transcription factors are key downstream signaling components of
the hedgehog pathway in vertebrates.
Increasing evidence suggests that Gli/Ci proteins are highly regulated
in the cell cytoplasm and nucleus. In the absence of hedgehog
signaling, Ci protein is retained in the cell cytoplasm as part of a
protein complex associated with microtubules containing the negative
regulators Costal2 and suppressor of fused (SuF) (24-27). Here
full-length Ci protein is proteolytically processed into a shortened
transcriptional repressor form (28, 29). In the presence of hedgehog
signaling, full-length Ci protein is transported into the nucleus to
activate hedgehog target genes (30). Once inside the nucleus, Gli
transcription factor activity is still modulated by a number of
different factors. CREB-binding protein, a general transcriptional
co-activator, can directly bind Ci or Gli3 and is believed to enhance
transcription in part through its acetylase activity (31-33). Recent
biochemical data also suggest that SuF may associate with SAP18 and
mSin3, forming a deacetlyase complex, resulting in Gli/Ci
transcriptional repression (34).
In this report, we describe our findings that Dyrk1 activated
Gli1-dependent gene transcription, but not LEF-1-, c-jun-,
or Elk-dependent gene transcription. Dyrk1 does this by
retaining Gli1 in the nucleus as well as by enhancing the
transcriptional activity. In addition, we show that Dyrk1 functionally
interacts with the Shh pathway to induce gene transcription and
differentiation in C3H10T1/2 cells.
Cell Culture, Transfection, and Reporter Gene Assay--
NIH3T3
cells and Cos-7 cells were maintained in Dulbecco's modified Eagle's
medium containing 10% fetal calf serum. C3H10T1/2 cells were cultured
in minimum essential medium Immunoprecipitation, Kinase Assay, and Western
Analysis--
Immunoprecipitation and Western analysis were performed
as described previously (35). For in vitro Dyrk kinase
assay, Gli1-HA or its mutants and Dyrk1-HA were separately expressed in
Cos-7 cells and immunoprecipitated by anti-HA antibodies. 24 h
later, cells were lysed, and HA-tagged proteins were immunoprecipitated with an anti-HA antibody. The immunocomplexes were mixed and then divided into two portions. One portion was washed, separated by SDS-PAGE, and analyzed by Western blotting using an anti-HA antibody, and the other was incubated at 30 °C for 30 min in the presence of
10 µCi of [32P]ATP and 10 µM ATP. The
kinase reactions were terminated by the addition of 4× SDS sample
buffer, and the samples were separated by SDS-PAGE and visualized using
a phosphorimager.
Immunofluorescence Staining--
NIH3T3 cells transfected with
appropriate expression plasmids were fixed for 15 min in
phosphate-buffered saline containing 2% paraformaldehyde, followed by
permeabilization in phosphate-buffered saline containing 0.2% Triton
X-100. HA-tagged Dyrk1 or Dyrk1KR was detected by immunofluorescence
staining using a red fluorescent Alexis dye-conjugated anti-HA
antibody, whereas the intracellular localization of GFP fusion proteins
was directly visualized under a fluorescence microscope simultaneously.
Nuclei were stained with Hoechst dye.
Alkaline Phosphatase Assay--
C3H10T1/2 cells were lysed 3 days after transfection. The cell lysates were mixed with the CDP-Star
chemiluminescent substrate for alkaline phosphatase as
instructed by the manufacturer (Tropix). After a 1-h incubation at room
temperature, the luminescence intensity was measured using the Wallac multicounter.
Effects of Dyrk1 and Mnb on Gene Transcription--
To investigate
the possible involvement of Dyrk1 in gene transcriptional regulation,
we examined the effects of Dyrk1 overexpression in a number of reporter
gene assay systems. We found that co-expression of Dyrk1 and Gli1
strongly induced Gli1-dependent gene transcription in the
presence of the 3'GliBS-Luc reporter construct, but not in the presence
of the mutant reporter construct, m3'GliBS-Luc (Fig.
1A). The 3'GliBS-Luc reporter
construct, as described previously (19), contains Gli DNA binding
sequences through which the production of the reporter, luciferase, is
regulated. In addition, we found that Dyrk1 enhanced the binding of
Gli1 to its response element in an electrophoretic mobility shift assay
(data not shown). The involvement of Dyrk1 in gene transcriptional
regulation of Gli1 appears to be specific because expression of Dyrk1
did not activate Elk-, c-Jun-, or LEF-1-mediated gene transcription in
NIH3T3 cells (Fig. 1, B
To determine whether activation of Gli1-dependent gene
transcription by Dyrk1 depends on its kinase activity, we obtained a
kinase-null mutant, Dyrk1KR, which contains a Lys-188 to Arg point
mutation at the ATP binding region of its kinase domain. Unlike
wild-type Dyrk1, this kinase-deficient mutant did not show any
synergistic effect with Gli1 (Fig.
2A). In addition, activation of Gli1-mediated gene transcription seems to be independent of Dyrk1
C-terminal sequences because deletion of C-terminal residues 498-763 located after the kinase domain did not affect its capacity to
induce Gli1-dependent gene transcription (data not
shown).
Dyrk1 Regulates Gli1 Nuclear Export--
Regulation of Ci
proteolysis has been proposed as a mechanism for regulation of its
transcriptional activity (36). Because there are no significant changes
in the levels of full-length Gli1 protein when Gli1 and Dyrk1 were
co-expressed (Fig. 2B), the processing of Gli1 protein may
not play an important role in Dyrk1-mediated Gli1 activation. In the
past several years, it has been reported that regulation of nuclear
trafficking represents a novel mechanism for the control of the
activities of gene transcriptional regulators (37). Two recent studies
(38, 39) as well as our data (see below) demonstrate that Gli1 and Ci
are nuclear shuttling proteins. Hedgehog signaling appears to regulate
the import of Ci (38). In addition, vertebrate Su(fu), a homolog of the Drosophila hegdgehog signaling protein suppressor of
fused, binds to Gli proteins (25, 39) and may retard Gli1 nuclear import (39, 42). We investigated whether Dyrk1, which is localized in
the nucleus (2), has any effect on the subcellular localization of
Gli1. To determine the intracellular localization of Gli1, we
constructed the expression plasmid Gli1-GFP. The intracellular localization of Gli1-GFP fusion protein was visualized under
fluorescence in the presence or absence of Dyrk1-HA. Dyrk1-HA and
nuclei were visualized after Gli1-GFP in the same cell and stained with
red fluorescent Alexis dye-conjugated anti-HA antibody and Hoechst dye,
respectively. Consistent with previous reports (9, 39), Dyrk1 and its
mutant, Dyrk1KR, were primarily localized in the nucleus (Fig.
3, E and H),
whereas the Gli1 protein was predominantly localized in the cytoplasm
in the absence of co-expressed Dyrk1 (Fig. 3A). However,
co-expression of Dyrk1-HA caused significant accumulation of Gli1-GFP
in the nucleus (Fig. 3D). More importantly, Dyrk1-mediated
nuclear accumulation of Gli1-GFP protein depended on Dyrk1 kinase
activity because Dyrk1KR could not induce nuclear accumulation of Gli1
protein (Fig. 3G). The levels of Gli1 in the nuclear
fraction from cells expressing Dyrk1 were also found to be higher than
those from cells expressing control protein Dyrk1 Phosphorylates Gli1--
Phosphorylation has recently
emerged as a major mechanism for regulating protein nuclear transport
(37). Because Dyrk1 kinase activity is essential for Gli1 nuclear
retention, we wanted to know whether Dyrk1 could phosphorylate Gli1
protein, and which domains might be phosphorylated. Gli1-HA or its
truncated mutants (Fig. 4A)
and Dyrk1-HA were separately expressed in Cos-7 cells and
immunoprecipitated by anti-HA antibodies. Then the immunocomplexes were
mixed in the presence of [32P]ATP. Significant
phosphorylation of Gli1-HA, Gli1N-HA, and Gli1C-HA, but not Gli1ZF-HA,
was observed in the presence of Dyrk1 (Fig. 4B). No
phosphorylation was detected in the absence of Dyrk1 (Fig. 4B) or in the presence of Dyrk1KR (data not shown). Although
Dyrk1 is a dual specificity kinase, the phosphorylation of Gli1 by
Dyrk1 appeared to be predominantly on Ser/Thr residues because we could not detect phosphotyrosines in Dyrk1-treated Gli1 or its mutants by
Western analysis using an anti-phosphotyrosine antibody (data not
shown). However, we were able to detect Dyrk1 autophosphorylation by
using the same anti-phosphotyrosine antibody (Fig. 2C). A
previous report has demonstrated that tyrosine autophosphorylation of
Dyrk1 is required for its kinase activity (1). These results, together with the observation that Dyrk1-mediated nuclear accumulation of Gli1
depends on its kinase activity, suggest that Dyrk1 may regulate nuclear
transport of Gli proteins via phosphorylation.
Dyrk1 phosphorylates both the N-terminal and C-terminal portions of
Gli1. To determine which portions of Gli1 are required for
Dyrk1-mediated nuclear retention, two Gli1 mutants, Gli1 Dyrk1 Stimulates Transcriptional Activity of Gli1--
With the
knowledge that Dyrk1 phosphorylates and retains Gli1 protein in the
nucleus, the next question is whether nuclear retention of Gli1 is the
sole mechanism for Dyrk1-induced Gli-dependent transcriptional activation. To address this question, we generated another Gli1 mutant, called Gli1-AHA-GFP, in which three amino acids
(Leu-Arg-Leu) in the core tetramer of the nuclear export sequence (NES)
were changed to Ala-His-Ala (Fig.
5A). As we expected, this
mutant accumulated in the nucleus independently of Dyrk1 (Fig.
5B). This result further confirmed that Gli1 NES is involved in Gli1 export, probably by interacting with the nuclear export receptor Crm1 (46). The transcriptional activity of Gli1-AHA was
determined using the 3'GliBS-Luc reporter assay. We found that Gli1-AHA
showed a higher basal transcriptional activity than the wild-type Gli1
(Fig. 5C). This augmented basal activity is probably due to
the increased accumulation of Gli mutant proteins in the nucleus. The
fact that basal activity of Gli1-AHA is less than the activity of the
wild-type Gli1 in the presence of Dyrk1 and that Gli1-AHA can be
further stimulated by co-expressed Dyrk1 suggests that Dyrk1 can also
stimulate the transcriptional activity of Gli1 in addition to retaining
Gli1 in the nucleus. The expression levels of wild-type Dyrk1 and its
AHA mutant are shown in Fig. 5D.
Dyrk1 Interacts with the Shh Signaling Pathway--
In the
presence of hedgehog signaling, increased levels of Gli/Ci proteins get
imported into the nucleus and activate downstream target genes (36,
47). Therefore, we wanted to know whether Dyrk1 could potentiate a Gli
response in cells undergoing Shh signaling. It was previously shown
that Shh could induce Gli-dependent transcriptional
activation of the 3'GliBS-Luc reporter gene and differentiation in
C3H10T1/2 embryonic fibroblast cells (48). Consistent with previous
reports, when C3H10T1/2 cells were co-transfected with cDNA
encoding Shh and 3'GliBS-Luc reporter gene, the cells produced more
luciferase activity than cells transfected with 3'GliBS-Luc reporter
gene alone (Fig. 6A).
Co-expression of Dyrk1 with Shh further increases reporter gene
activity, which is more than the sum of those in cells expressing Dyrk1
or Shh alone, suggesting that Shh and Dyrk1 acted synergistically. The
effect of Dyrk1 on Shh-induced differentiation of C3H10T1/2 cells was also examined by assaying changes in alkaline phosphatase activity as
described previously (48, 49). Again, co-expression of Dyrk1 with Shh
demonstrated a synergistic effect, this time in stimulating alkaline
phosphatase activity (Fig. 6B).
To determine whether the Shh-activated pathway directly regulates
Dyrk1, we examined whether Shh could stimulate Dyrk1 phosphorylation. Dyrk1 was immunoprecipitated from cells expressing Dyrk1 alone or from
cells co-expressing Dyrk and Shh. The phosphotyrosine content of
precipitated Dyrk was detected using a phosphotyrosine-specific antibody. Shh did not stimulate phosphorylation of Dyrk (Fig. 6D). In agreement with this, the Dyrk kinase-deficient
mutant did not inhibit Shh-induced production of alkaline
phosphatase in C3H10T1/2 cells (Fig. 6C). Thus, Dyrk does
not appear to be directly regulated by Shh.
In this study, we provide biochemical evidence that Dyrk1, a
nuclear protein kinase, and its Drosophila homolog
mnb can enhance the transcriptional activity of Gli1. In
part, this increase in transcriptional activity is a result of elevated
Gli1 protein levels in the nucleus. However, the ability of Dyrk1 to
induce transcriptional activity of Gli1-AHA, a nuclear export mutant, also suggests that Dyrk1 may be more directly involved in modulating Gli1 transcriptional activity. We also show that Gli1 is phosphorylated in the presence of Dyrk1 and that Dyrk1 kinase activity is essential for Gli1 nuclear retention and its increased transcriptional activity. In addition, Dyrk1 can synergistically function with Shh to stimulate Gli reporter gene activity and differentiate C3H10T1/2 cells.
Nuclear cytoplasmic trafficking has been shown to be one mechanism by
which transcription factor function can be modulated (37). Previous
work on Gli/Ci, as well as our work presented here, has demonstrated
that Gli/Ci proteins are nuclear cytoplasmic shuttling proteins. The
nuclear export of Gli1/Ci appears to depend on Crm1, a nuclear export
receptor, because the typical NES sequences are required for export
(Fig. 5A) and can be blocked by leptomycin B (39) (data not
shown). Chen et al. (38) showed that regulation of
nuclear-cytoplasmic transport might be one mechanism used by Hh to
regulate Ci. Hh may not only prevent Ci from proteolytic cleavage but
may also increase levels of Ci in the nucleus by promoting its nuclear import.
Phosphorylation has been shown to have different effects on the
interactions between shuttling proteins and Crm1. Phosphorylation of
MK2 at a specific site was shown to unmask the NES, thus
facilitating binding to Crm1 and stimulating its nuclear export (50),
whereas phosphorylation at serine residues in the NES of cyclin B
blocked binding to Crm1 and inhibited its nuclear export (45). In this report, we showed that overexpression of Dyrk1, a nuclear localized kinase, led to the accumulation of Gli1 in the nucleus. We also showed
that Dyrk1 kinase activity is necessary for Gli1 nuclear retention and
that Gli1 is phosphorylated at multiple sites in the presence of Dyrk1
(Fig. 4). Therefore, one potential mechanism by which Dyrk1 can
regulate Gli1 function is by regulating its nuclear export through phosphorylation.
However, the accumulation of Gli1 in the nucleus as a result of Dyrk1
kinase activity could also be from an increase in protein-protein interactions. In support of this idea, recent work has shown that co-expression of Zic proteins, nuclear localized transcription factors,
with members of the Gli family also results in accumulation of Gli
proteins in the nucleus (44). Our studies demonstrate that Dyrk1 kinase
activity does more than retain Gli1 in the nucleus-it also stimulates
Gli1 transcriptional activity. Reporter gene studies in which Dyrk1 and
Gli1-AHA were co-expressed clearly show that Gli1 transcriptional
activity can be further enhanced by Dyrk1. This suggests that Dyrk1 may
be more directly involved in modulating the transcriptional activity of
Gli1 in the nucleus. Therefore, it is possible that Dyrk1
phosphorylation of Gli1 results in more efficient association of Gli1
with other transcriptional cofactors, thus delaying its nuclear export.
Consistent with our observation that Dyrk1 can stimulate Gli1
transcriptional activity, previous work on Dyrk1 has suggested that it
may also regulate the function of other transcription factors such as
CREB, Forkhead, and signal transducers and activators of transcription
3 (15-17). There is also evidence that
homeodomain-interacting protein kinase 2, a Dyrk-like kinase, can bind
p53 and CREB-binding protein to enhance transcription (13, 14).
Collectively, these studies provide increasing evidence that one
possible role of nuclear localized Dyrk kinases may be to modulate
transcription factor function. However, how specific or general a role
remains to be determined.
The distinct effect of Hh and Dyrk on the nuclear transport of the
Ci/Gli proteins suggests that Dyrk1 may not be a direct signaling
component within the Hh pathway. This is consistent with our
observations that Shh did not stimulate phosphorylation of Dyrk1 and
that the kinase-deficient mutant of Dyrk1 could not inhibit Shh-induced
effects in C3H10T1/2 cells. However, the synergistic effect between
Dyrk1 and Shh in enhancing Gli-dependent gene transcription and increasing alkaline phosphatase activity in C3H10T1/2 cells suggests that these two pathways may functionally interact. Although Dyrk1 is not essential for Hh signaling, levels of Dyrk1 kinase activity in the nucleus may determine how robust cells respond to Hh
signaling. Thus, Gli/Ci proteins may be the cellular targets for at
least two distinct signaling pathways: one regulated by the Hh proteins
in the cytoplasm, and the other mediated by the Dyrk kinases in the nucleus.
The inability of Shh to stimulate Dyrk1 phosphorylation still leaves
the following question: what regulates Dyrk kinase activity? Similar to
mitogen-activated protein kinases, Dyrks contain an activation loop
within the catalytic domain (2). Therefore, early studies hypothesized
that Dyrk activation may be analogous to mitogen-activated protein
kinase activation, via phosphorylation by an upstream kinase (1).
However, recent transfection studies in mammalian cells favor the
possibility that, unlike mitogen-activated protein kinases, Dyrk1 can
activate itself through auto-phosphorylation (43). This may explain why
overexpression of Dyrk1 alone results in vigorous kinase activity. It
is also interesting to speculate that if Dyrk1a can activate itself
through autophosphorylation, then gene dosage and transcriptional
control may be important regulatory mechanisms. Another possibility is
that Dyrk, like glycogen synthase kinase 3, might be negatively
regulated by yet unknown upstream kinases or even phosphatases.
Developmental studies of the Dyrk1/mnb class of Dyrk kinases
suggest an important role in proper brain development. Mutations in the
Drosophila mnb gene that cause a reduction
protein expression were associated with defects in neuroblast
proliferation and specific behavioral abnormalities (8). The mammalian
homolog of mnb, Dyrk1a, has been mapped to the Down's
syndrome critical region of chromosome 21, and transgenic mice
retaining an extra copy of Dyrk1 have learning deficits (10-12).
Several studies have also demonstrated the involvement of the Hh-Gli
signaling pathway in neuronal proliferation (47). In the vertebrate
central nervous system, Shh acts as a mitogen for a number of neuronal
precursor cells, including those located in the spinal cord and retina, oligodendrocyte cell precursors in the neural tube, and granule neuronal cell precursors in the cerebellum (40, 41, 47). Studies on the
hedgehog receptor Patched1 also reveal the importance of repressing the
Hh pathway during brain development. Loss of function mutations in
Patched1, which aberrantly activates hedgehog signaling, result
in overproliferation of granule cell precursors in the cerebellum (41).
Because Hh and Dyrk1/mnb pathways are important for central
nervous system development, it is interesting to speculate whether or
not both these pathways interact with each other during neuronal
development in vivo. Future studies will focus on the
potential for Hh and Dyrk1 pathways to interact with each other during
neuronal development through modulating Gli transcriptional activity.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
medium with 10% heat-inactivated fetal
calf serum. Transfection was carried out using LipofectAMINE Plus as
suggested by the manufacturer (Invitrogen). The transfection was
stopped after 3 h, and cell extracts were collected 24 h
later for luciferase assays, kinase assays, and Western analysis.
Luciferase assays were performed using the Roche Molecular Biochemicals
Luciferase Assay Kit as instructed. Cell lysates were first taken to
determine the fluorescence intensity emitted by GFP in a Wallac
multicounter, which is capable of counting fluorescence and
luminescence. Then, luciferase substrate was added to the cell lysates,
and luciferase activities were determined by measuring luminescence
intensity using the same counter. Luminescence intensity was normalized
against fluorescence intensity. DNA concentrations were adjusted if
transfection of any of the cDNAs resulted in significant
differences between normalized and non-normalized data.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
D). In addition, many other protein
kinases, including mitogen-activated protein kinase/extracellular
signal-regulated kinase kinase, Src, and casein kinase I
, while
stimulating Elk-, c-Jun-, and LEF-1-dependent gene
transcription, respectively, failed to induce
Gli1-dependent gene transcription (Fig. 1A). The
Dyrk1 Drosophila homolog mnb, which shares 85%
amino acid sequence homology with Dyrk1 in its kinase domain (1, 8), was also tested, and it was found to be a potent activator of Gli1
(Fig. 1A).

View larger version (22K):
[in a new window]
Fig. 1.
Effects of the Dyrk kinases on gene
transcription. NIH3T3 cells were co-transfected with
(A) 0.1 µg of 3'GliBS-Luc reporter plasmid, 0.1 µg of
enhanced GFP expression construct, and 0.2 µg of LacZ, Dyrk1, Mnb,
mitogen-activated protein kinase/extracellular signal-regulated kinase
kinase, Src, or casein kinase I
in the presence or absence of 0.1 µg of Gli1 expression constructs; (B
D) 0.15 µg of GFP
expression construct, 0.2 µg of LacZ, Dyrk1, activated
mitogen-activated protein kinase/extracellular signal-regulated kinase
kinase, activated Src protein kinase, or casein kinase I
(CKI
) and 0.15 µg of Elk-luciferase reporter plasmid
(B), c-Jun-luciferase reporter plasmid (C), or
LEF-luciferase reporter plasmid (D). LacZ expression plasmid
was used to make the total amount of DNA equal (0.5 µg/well) in all
transfections. 1 day later, cells were lysed, and GFP levels and
luciferase activity were determined. The luciferase activities
presented were normalized against the levels of GFP expression. Data
show similar tendencies with or without normalization. Experiments were
carried out in triplicates and repeated at least three times. The
representative experiments are shown, and error bars
represent S.D.s.

View larger version (20K):
[in a new window]
Fig. 2.
Dyrk-induced transcriptional activity depends
on Dyrk kinase activity and Gli target sequence. A,
NIH3T3 cells were transfected with 0.1 µg of 3'GliBS-Luc or
m3'GliBS-Luc reporter plasmid, 0.1 µg of enhanced GFP expression
construct, and 0.1 µg of Gli1 expression plasmid in the presence or
absence of 0.2 µg of Dyrk1 or Dyrk1KR expression constructs. The
luciferase activity was determined and presented as described in Fig.
1. B and C, the expression levels of Gli1,
Dyrk1, and Dyrk1KR were determined using Western analysis with anti-myc
or anti-HA antibodies that recognize myc-tagged Gli1 or HA-tagged Dyrk.
Tyrosine phosphorylation of Dyrk1 was detected by an
anti-phosphotyrosine antibody.
-galactosidase (data not
shown).

View larger version (84K):
[in a new window]
Fig. 3.
Regulation of nuclear transport of Gli1 by
Dyrk1. NIH3T3 cells were transfected with Gli1-GFP (A
and B) or GFP (C) or co-transfected with Gli1-GFP
and Dyrk1-HA (D
F) or Gli1-GFP and DyrkKR-HA
(G
I). Localization of Gli1-GFP or GFP was detected by
green fluorescence (A, C, D, and
G), and co-expressed HA-tagged Dyrk1 was visualized in the
same cell by immunofluorescence staining with red Alexis dye-conjugated
anti-HA antibodies (E and H), whereas the nucleus
was visualized by Hoechst staining (B, F,
and I).

View larger version (41K):
[in a new window]
Fig. 4.
Phosphorylation of Gli1 by Dyrk1.
A, schematic representation of Gli1 and Gli1 mutants.
Some Gli1 structural motifs, including zinc finger (ZF),
nuclear localization signal (NLS), NES, and transcriptional
activation domain (TAD), are denoted. B,
Cos-7 cells were transfected with Gli1-HA, its mutants, Dyrk1-HA, or
Dyrk1KR-HA expression plasmids. 24 h later, cells were lysed, and
HA-tagged proteins were immunoprecipitated with an anti-HA antibody.
The immunocomplexes were mixed and then divided into two portions. One
was incubated with [32P]ATP for in vitro
kinase assay, and the other was washed, separated by SDS-PAGE, and
analyzed by Western blotting using an anti-HA antibody.
N-GFP (amino
acids 195-1107) and Gli1
C-GFP (amino acids 1-410),
were generated, and the intracellular localization was determined in the presence or absence of co-expressed Dyrk1. We found that both Gli1
N-GFP and Gli1
C-GFP were predominantly localized in the cytoplasm despite the presence of Dyrk1. However, we noticed that Gli1
C-GFP was detected in the nuclei of a small fraction of cells that co-express both Gli1
C-GFP and Dyrk1 (data not shown).
Nevertheless, we believe that both the N-terminal and C-terminal
portions of Gli1 are important for efficient nuclear retention of Gli1
by Dyrk1.

View larger version (37K):
[in a new window]
Fig. 5.
Dyrk1 stimulates the transcriptional activity
of Gli1. A, schematic representation of the Gli1
molecule and Gli1 mutants. B, nuclear localization of
Gli1-AHA mutant expressed in NIH3T3 cells. C,
transcriptional activity of Gli1-AHA. Transfection of NIH3T3 cells was
carried out, and luciferase activity was determined and presented as
described in the Fig. 1 legend. D, the expression
levels of wild-type Gli1 and its AHA mutant.

View larger version (37K):
[in a new window]
Fig. 6.
Functional interaction between Dyrk1 and the
Shh signaling pathway. A, Shh acted
synergistically with Dyrk1 to induce gene transcription in C3H10T1/2
cells. C3H10T1/2 cells were co-transfected with 0.1 µg of 3'GliBS-Luc
reporter plasmid, 0.15 µg of GFP expression construct, and 0.125 µg
of mouse Shh expression plasmid or 0.125 µg of Gli1 expression
plasmid with or without 0.125 µg of Dyrk1 or Dyrk1KR. LacZ expression
plasmid was used to make the total amount of DNA equal (0.5 µg/well)
in all transfections. Luciferase assays were carried out 3 days after
transfection, and the data were processed and presented as described in
the Fig. 1 legend. B, Dyrk1 acted synergistically with
Shh and Gli1 to induce differentiation of C3H10T1/2 cells. C3H10T1/2
cells were transfected with 0.25 µg of Dyrk1 and 0.25 µg of LacZ,
mouse Shh, or Gli1. The alkaline phosphatase (AP) activities
were determined 3 days after transfection. C, Dyrk1KR
failed to inhibit Shh effect. C3H10T1/2 cells were transfected as
described in B, except that wild-type Dyrk1 was
replaced with varying amounts of Dyrk1KR. LacZ expression plasmid was
used to make the total amount of DNA equal (0.5 µg/well) in all
transfections. D, tyrosine phosphorylation of Dyrk1.
C3H10T1/2 cells were transfected with 0.25 µg of Dyrk1 and 0.25 µg
of LacZ or Shh. Dyrk-HA was precipitated using antibodies specific to
HA. The immunocomplexes were detected with anti-HA and
anti-phosphotyrosine antibodies, respectively.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
| |
ACKNOWLEDGEMENTS |
|---|
We thank Walter Becker and Hans-Georg Joost for Dyrk cDNAs, Kenneth W. Kinzler and Bert Vogelstein for Gli1, Dr. Hiroshi Sasaki for the 3'GliBS-Luc and m3'GliBS-Luc reporter constructs, Owen Witte for Src, and Rudolf Grosschedl for LEF-1 expression plasmid and reporter construct. We also thank Yan Yang for generous support and helpful discussion and Anne Paxhia for technical help.
| |
FOOTNOTES |
|---|
* This work was supported by grants from the National Institutes of Health and American Cancer Society and by American Heart Association Established Investigator Award (to D. W.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶¶ To whom correspondence should be addressed: Dept. of Genetics and Developmental Biology, University of Connecticut Health Center, MC3301, 263 Farmington Ave., Farmington, CT 06030. Tel.: 860-679-8818; Fax: 860-679-8345; E-mail: dwu@neuron.uchc.edu.
Published, JBC Papers in Press, July 22, 2002, DOI 10.1074/jbc.M206743200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: Dyrk, dual specificity Yak1-related kinase; Shh, Sonic hedgehog; NES, nuclear export sequence; GFP, green fluorescent protein; CREB, cAMP-response element-binding protein; HA, hemagglutinin; LEF, lymphoid enhancer factor; Luc, luciferase; Hh, hedgehog.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Kentrup, H.,
Becker, W.,
Heukelbach, J.,
Wilmes, A.,
Schurmann, A.,
Huppertz, C.,
Kainulainen, H.,
and Joost, H. G.
(1996)
J. Biol. Chem.
271,
3488-3495 |
| 2. | Becker, W., and Joost, H. G. (1999) Prog. Nucleic Acid Res. Mol. Biol. 62, 1-17[Medline] [Order article via Infotrieve] |
| 3. | Miyata, Y., and Nishida, E. (1999) Biochem. Biophys. Res. Commun. 266, 291-295[CrossRef][Medline] [Order article via Infotrieve] |
| 4. |
Kim, Y. H.,
Choi, C. Y.,
Lee, S. J.,
Conti, M. A.,
and Kim, Y.
(1998)
J. Biol. Chem.
273,
25875-25879 |
| 5. |
Moilanen, A. M.,
Karvonen, U.,
Poukka, H.,
Janne, O. A.,
and Palvimo, J. J.
(1998)
Mol. Biol. Cell
9,
2527-2543 |
| 6. | Shang, E., Wang, X., Huang, J., Yoshida, W., Kuroiwa, A., and Wolgemuth, D. J. (2000) Mol. Reprod. Dev. 55, 372-378[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Hartley, A. D., Ward, M. P., and Garrett, S. (1994) Genetics 136, 465-474[Abstract] |
| 8. | Tejedor, F., Zhu, X. R., Kaltenbach, E., Ackermann, A., Baumann, A., Canal, I., Heisenberg, M., Fischbach, K. F., and Pongs, O. (1995) Neuron 14, 287-301[CrossRef][Medline] [Order article via Infotrieve] |
| 9. |
Becker, W.,
Weber, Y.,
Wetzel, K.,
Eirmbter, K.,
Tejedor, F. J.,
and Joost, H. G.
(1998)
J. Biol. Chem.
273,
25893-25902 |
| 10. | Song, W. J., Sternberg, L. R., Kasten-Sportes, C., Keuren, M. L., Chung, S. H., Slack, A. C., Miller, D. E., Glover, T. W., Chiang, P. W., Lou, L., and Kurnit, D. M. (1996) Genomics 38, 331-339[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Shindoh, N., Kudoh, J., Maeda, H., Yamaki, A., Minoshima, S., Shimizu, Y., and Shimizu, N. (1996) Biochem. Biophys. Res. Commun. 225, 92-99[CrossRef][Medline] [Order article via Infotrieve] |
| 12. |
Altafaj, X.,
Dierssen, M.,
Baamonde, C.,
Marti, E.,
Visa, J.,
Guimera, J.,
Oset, M.,
Gonzalez, J. R.,
Florez, J.,
Fillat, C.,
and Estivill, X.
(2001)
Hum. Mol. Genet.
10,
1915-1923 |
| 13. | D'Orazi, G., Cecchinelli, B., Bruno, T., Manni, I., Higashimoto, Y., Saito, S., Gostissa, M., Coen, S., Marchetti, A., Del Sal, G., Piaggio, G., Fanciulli, M., Appella, E., and Soddu, S. (2002) Nat. Cell. Biol. 4, 11-19[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Hofmann, T. G., Moller, A., Sirma, H., Zentgraf, H., Taya, Y., Droge, W., Will, H., and Schmitz, M. L. (2002) Nat. Cell. Biol. 4, 1-10[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Woods, Y. L., Rena, G., Morrice, N., Barthel, A., Becker, W., Guo, S., Unterman, T. G., and Cohen, P. (2001) Biochem. J. 355, 597-607[CrossRef][Medline] [Order article via Infotrieve] |
| 16. |
Yang, E. J.,
Ahn, Y. S.,
and Chung, K. C.
(2001)
J. Biol. Chem.
276,
39819-39824 |
| 17. | Matsuo, R., Ochiai, W., Nakashima, K., and Taga, T. (2001) J. Immunol. Methods 247, 141-151[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Von Ohlen, T., and Hooper, J. E. (1997) Mech. Dev. 68, 149-156[CrossRef][Medline] [Order article via Infotrieve] |
| 19. | Sasaki, H., Hui, C., Nakafuku, M., and Kondoh, H. (1997) Development 124, 1313-1322[Abstract] |
| 20. | Aza-Blanc, P., and Kornberg, T. B. (1999) Trends Genet. 15, 458-462[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Hammerschmidt, M., Brook, A., and McMahon, A. P. (1997) Trends Genet. 13, 14-21[CrossRef][Medline] [Order article via Infotrieve] |
| 22. |
Ingham, P. W.,
and McMahon, A. P.
(2001)
Genes Dev.
15,
3059-3087 |
| 23. | McMahon, A. P. (2000) Cell 100, 185-188[CrossRef][Medline] [Order article via Infotrieve] |
| 24. | Stone, D. M., Murone, M., Luoh, S., Ye, W., Armanini, M. P., Gurney, A., Phillips, H., Brush, J., Goddard, A., de Sauvage, F. J., and Rosenthal, A. (1999) J. Cell Sci. 112, 4437-4448[Abstract] |
| 25. | Pearse, R. V., II, Collier, L. S., Scott, M. P., and Tabin, C. J. (1999) Dev. Biol. 212, 323-336[CrossRef][Medline] [Order article via Infotrieve] |
| 26. | Monnier, V., Dussillol, F., Alves, G., Lamour-Isnard, C., and Plessis, A. (1998) Curr. Biol. 8, 583-586[CrossRef][Medline] [Order article via Infotrieve] |
| 27. | Methot, N., and Basler, K. (2000) Development 127, 4001-4010[Abstract] |
| 28. | Muller, B., and Basler, K. (2000) Development 127, 2999-3007[Abstract] |
| 29. | Price, M. A., and Kalderon, D. (2002) Cell 108, 823-835[CrossRef][Medline] [Order article via Infotrieve] |
| 30. | Wang, Q. T., and Holmgren, R. A. (2000) Development 127, 3131-3139[Abstract] |
| 31. | Akimaru, H., Chen, Y., Dai, P., Hou, D. X., Nonaka, M., Smolik, S. M., Armstrong, S., Goodman, R. H., and Ishii, S. (1997) Nature 386, 735-738[CrossRef][Medline] [Order article via Infotrieve] |
| 32. |
Chen, Y.,
Goodman, R. H.,
and Smolik, S. M.
(2000)
Mol. Cell. Biol.
20,
1616-1625 |
| 33. |
Dai, P.,
Akimaru, H.,
Tanaka, Y.,
Maekawa, T.,
Nakafuku, M.,
and Ishii, S.
(1999)
J. Biol. Chem.
274,
8143-8152 |
| 34. |
Cheng, S. Y.,
and Bishop, J. M.
(2002)
Proc. Natl. Acad. Sci. U. S. A.
99,
5442-5447 |
| 35. | Mao, J., Xie, W., Yuan, H., Simon, M. I., Mano, H., and Wu, D. (1998) EMBO J. 17, 5638-5646[CrossRef][Medline] [Order article via Infotrieve] |
| 36. | Ingham, P. W. (1998) EMBO J. 17, 3505-3511[CrossRef][Medline] [Order article via Infotrieve] |
| 37. | Hood, J. K., and Silver, P. A. (1999) Curr. Opin. Cell Biol. 11, 241-247[CrossRef][Medline] [Order article via Infotrieve] |
| 38. | Chen, C. H., von Kessler, D. P., Park, W., Wang, B., Ma, Y., and Beachy, P. A. (1999) Cell 98, 305-316[CrossRef][Medline] [Order article via Infotrieve] |
| 39. | Kogerman, P., Grimm, T., Kogerman, L., Krause, D., Unden, A. B., Sandstedt, B., Toftgard, R., and Zaphiropoulos, P. G. (1999) Nat. Cell. Biol. 1, 312-319[CrossRef][Medline] [Order article via Infotrieve] |
| 40. | Rowitch, D. H., St.-, Jacques, B., Lee, S., Flax, J. D., Snyder, E. Y., and McMahon, A. P. (1999) Development 19, 8954-8965 |
| 41. | Wechsler-Reya, R. J., and Scott, M. P. (1999) Neuron 22, 103-114[CrossRef][Medline] [Order article via Infotrieve] |
| 42. | Ding, Q., Fukami, S., Meng, X., Nishizaki, Y., Zhang, X., Sasaki, H., Dlugosz, A., Nakafuku, M., and Hui, C.-C. (2000) Curr. Biol. 9, 1119-1122 |
| 43. | Himpel, S., Panzer, P., Eirmbter, K., Czajkowska, H., Sayed, M., Packman, L. C., Blundell, T., Kentrup, H., Grotzinger, J., Joost, H. G., and Becker, W. (2001) Biochem. J. 359, 497-505[CrossRef][Medline] [Order article via Infotrieve] |
| 44. |
Koyabu, Y.,
Nakata, K.,
Mizugishi, K.,
Aruga, J.,
and Mikoshiba, K.
(2001)
J. Biol. Chem.
276,
6889-6892 |
| 45. |
Yang, J.,
Bardes, E. S.,
Moore, J. D.,
Brennan, J.,
Powers, M. A.,
and Kornbluth, S.
(1998)
Genes Dev.
12,
2131-2143 |
| 46. | Ullman, K. S., Powers, M. A., and Forbes, D. J. (1997) Cell 90, 967-970[CrossRef][Medline] [Order article via Infotrieve] |
| 47. | Altaba, A. R. I. (1999) Trends Genet. 15, 418-425[CrossRef][Medline] [Order article via Infotrieve] |
| 48. | Murone, M., Rosenthal, A., and de Sauvage, F. J. (1999) Curr. Biol. 9, 76-84[CrossRef][Medline] [Order article via Infotrieve] |
| 49. | Kinto, N., Iwamoto, M., Enomoto-Iwamoto, M., Noji, S., Ohuchi, H., Yoshioka, H., Kataoka, H., Wada, Y., Yuhao, G., Takahashi, H. E., Yoshiki, S., and Yamaguchi, A. (1997) FEBS Lett. 404, 319-323[CrossRef][Medline] [Order article via Infotrieve] |
| 50. | Engel, K., Kotlyarov, A., and Gaestel, M. (1998) EMBO J. 17, 3363-3371[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
T. Shimokawa, U. Tostar, M. Lauth, R. Palaniswamy, M. Kasper, R. Toftgard, and P. G. Zaphiropoulos Novel Human Glioma-associated Oncogene 1 (GLI1) Splice Variants Reveal Distinct Mechanisms in the Terminal Transduction of the Hedgehog Signal J. Biol. Chem., May 23, 2008; 283(21): 14345 - 14354. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Eichberger, A. Kaser, C. Pixner, C. Schmid, S. Klingler, M. Winklmayr, C. Hauser-Kronberger, F. Aberger, and A.-M. Frischauf GLI2-specific Transcriptional Activation of the Bone Morphogenetic Protein/Activin Antagonist Follistatin in Human Epidermal Cells J. Biol. Chem., May 2, 2008; 283(18): 12426 - 12437. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Neill, W. J. Harrison, M. S. Ikram, T. D.L. Williams, L. S. Bianchi, S. K. Nadendla, J. L. Green, L. Ghali, A.-M. Frischauf, E. A. O'Toole, et al. GLI1 repression of ERK activity correlates with colony formation and impaired migration in human epidermal keratinocytes Carcinogenesis, April 1, 2008; 29(4): 738 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Burkart, J. D. Wren, J. I. Herschkowitz, C. M. Perou, and H. R. Garner Clustering microarray-derived gene lists through implicit literature relationships Bioinformatics, August 1, 2007; 23(15): 1995 - 2003. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lauth, A. Bergstrom, T. Shimokawa, and R. Toftgard Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists PNAS, May 15, 2007; 104(20): 8455 - 8460. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Alvarez, X. Altafaj, S. Aranda, and S. de la Luna DYRK1A Autophosphorylation on Serine Residue 520 Modulates Its Kinase Activity via 14-3-3 Binding Mol. Biol. Cell, April 1, 2007; 18(4): 1167 - 1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Kelly and Z. Rahmani DYRK1A Enhances the Mitogen-activated Protein Kinase Cascade in PC12 Cells by Forming a Complex with Ras, B-Raf, and MEK1 Mol. Biol. Cell, August 1, 2005; 16(8): 3562 - 3573. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Nguyen, A. L. Chokas, B. Stecca, and A. R. i Altaba Cooperative requirement of the Gli proteins in neurogenesis Development, July 15, 2005; 132(14): 3267 - 3279. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Di Marcotullio, E. Ferretti, E. De Smaele, B. Argenti, C. Mincione, F. Zazzeroni, R. Gallo, L. Masuelli, M. Napolitano, M. Maroder, et al. RENKCTD11 is a suppressor of Hedgehog signaling and is deleted in human medulloblastoma PNAS, July 20, 2004; 101(29): 10833 - 10838. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Sitz, M. Tigges, K. Baumgartel, L. G. Khaspekov, and B. Lutz Dyrk1A Potentiates Steroid Hormone-Induced Transcription via the Chromatin Remodeling Factor Arip4 Mol. Cell. Biol., July 1, 2004; 24(13): 5821 - 5834. [Abstract] [Full Text] [PDF] |
||||
![]() |